Contributors

Meet some of the people featured in the October 2017 issue of The Scientist.

Written byAggie Mika
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

BRAD ZIEGLERAndrew Read’s interest in natural history and evolution began when he was a child growing up in New Zealand. The islands are home to many “strange and weird birds and animals,” he says; their uniqueness and diversity prompted him to think about how they came to be. After obtaining a bachelor’s degree from the University of Otago, Read moved to the University of Oxford to pursue graduate studies in bird evolution. There, his interests began to diverge from birds to something much smaller and faster-evolving: pathogens. The pace of infections enthralled him, and he recognized that by studying infectious disease, he could observe evolution in real time. “I’ve been working on them ever since,” he says. How pathogens evolve is fundamentally important to human health, he says, and such research could positively affect society. After a series of faculty positions, first at the University of Tromsø in Norway and then the University of Edinburgh, Read moved to the U.S. in 2007 to set up a lab at Penn State’s Center for Infectious Disease Dynamics. Throughout his career, he’s pursued a variety of questions from a population-biology perspective, including why certain pathogens make us sicker than others, how pathogens compete within the same host, and what factors lead to drug resistance.

PETER KERRIn his early years as a practicing veterinarian, Peter Kerr had no intention of pursuing a career in research. “I thought I wanted to be a country veterinarian,” he says. “I loved working with animals.” But after working as a consultant to help control disease on pig farms, Kerr began to wonder how the same pathogen could be completely benign on one farm and cause rampant disease on another. To understand the answers to this question, Kerr knew he needed to arm himself with a solid background in molecular virology. This became the focus of his PhD studies at the Australian National University, and ultimately, “led me into this area of viral pathogenesis, of trying to understand how viruses cause disease,” he explains.

After completing his PhD, Kerr was recruited by the Commonwealth Scientific and Industrial Research Organisation (CSIRO) in 1990. There he spent 24 years pursuing his interest in viral virulence. He then moved to the University of Sydney, from which he officially retired at the end of last year. Unofficially, however, “I’m keeping busy.” Kerr is an honorary fellow at the Marie Bashir Institute at the University of Sydney, and since 2008, he’s been working with colleagues Andrew Read and Edward Holmes on questions surrounding the evolution of viral virulence.

In this issue, Read and Kerr delve into the evolution of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

October 2017

A Natural Archive

The practical challenges of storing data in DNA

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies